Chat with us, powered by LiveChat

In Vitro Diagnostics (IVD) Quality Control Market (Product and Service - Data Management Solutions, Quality Control Products, and Quality Assurance Services; Application - Immunochemistry, Microbiology, Coagulation/Hemostasis, Clinical Chemistry, Molecular Diagnostics, Hematology, and Other Applications; Manufacturer Type - OEMs, and Third-party Control Manufacturers; End User - Clinical Laboratories, Hospitals, Research and Academic Institutes, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

In Vitro Diagnostics (IVD) Quality Control Market (Product and Service - Data Management Solutions, Quality Control Products, and Quality Assurance Services; Application - Immunochemistry, Microbiology, Coagulation/Hemostasis, Clinical Chemistry, Molecular Diagnostics, Hematology, and Other Applications; Manufacturer Type - OEMs, and Third-party Control Manufacturers; End User - Clinical Laboratories, Hospitals, Research and Academic Institutes, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR0705 Category: Healthcare & Medical Devices Published: October, 2023

A recent report published by Infinium Global Research on in vitro diagnostics (IVD) quality control market provides in-depth analysis of segments and sub-segments in the global as well as regional in vitro diagnostics (IVD) quality control market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional in vitro diagnostics (IVD) quality control market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global in vitro diagnostics (IVD) quality control market.

Market Insight:

The global In Vitro Diagnostics (IVD) quality control market was valued at USD 25962.7 million in 2022 and is expected to reach USD 64094.9 million in 2030, with a CAGR of 10.4% during the forecast period 2023-2030.

In-vitro diagnostic tests are often performed to detect the various communicable and non-communicable diseases. These types of diagnostic test use blood as their sample. Alongside the test detection, this type of diagnosis allows the medical professionals to screen patient’s wellbeing by curing diseases. Additionally, these tests also navigate the healthcare professionals to identify the best possible treatment type. Additionally, the IVQ quality controls are the means to evaluate the reliability and validity of these tests. Molecular diagnostics, blood-based controls, immunochemistry, and clinical chemistry are some of the most commonly used quality control procedures in IVD. The market growth of in vitro diagnostics testing and quality control products is likely to be fast over the forecast years is owing to an increase in the global geriatric population. Nevertheless, one of the serious threats to the In-vitro Diagnostics (IVD) quality controls market is an unavailability of stringent regulations and standards in the low- and middle-income countries.

The flourishing number of scientifically approved laboratories across the globe act as one of the foremost factors riding the increase of the In-vitro Diagnostics (IVD) quality control market. The growth in the geriatric population and consequent increase in the prevalence of persistent and infectious chronic diseases accelerate the use of these diagnostics kits. The significant rise in the adoption of POC devices in developed regions and the upward push within the range of approved clinical laboratories further influence the market. Conversely, additional fees and price range constraints in hospitals and laboratories, and unfavourable repayment eventualities for IVD exams are expected to obstruct the market growth. The lack of policies for scientific laboratory accreditation and stringent product approval procedure is projected to undertaking the In-vitro Diagnostics (IVD) quality control market. Additionally, advancements in healthcare infrastructure, high disposable earnings, and the surge in healthcare expenditure, affect the In-vitro Diagnostics (IVD) quality control market. Furthermore, the upward thrust in call for multi-test chemical controls extends profitable opportunities to the key market players.

Global In Vitro Diagnostics (IVD) Quality Control Market | IGR

The In-vitro Diagnostics (IVD) quality controls market based on geography can be segmented into North America, Asia-Pacific, South America, Europe, and the Rest of the World. The North American region is expected to control the in vitro diagnostics quality controls market during 2023-2030. Under the influence of highly developed healthcare infrastructure, increasing number of geriatric populations, growing incidences of cancer and increased awareness among patients for early diagnosis and treatment. Furthermore, an increase in expenditure on R&D both private and public is setting in more innovative technologies together with promoting development. At the fastest rate, Asia Pacific will register its growth. An increase in communicable and noncommunicable diseases as well as a rise in public healthcare funding of some main developing economies such us China or India.

Report Scope of the In Vitro Diagnostics (IVD) Quality Control Market:

Report Coverage Details
Market Size in 2022 USD 25962.7 Million
Market Size by 2030 USD 64094.9 Million
Growth Rate from 2023 to 2030 CAGR of 10.4%
Largest Market North America
No. of Pages 300
Market Drivers
  • The increase in the number of accredited clinical laboratories across that acts as one of the major factors driving the growth of the In-vitro Diagnostics (IVD) quality control market.

  • The increase in the geriatric population and consequent increase in the occurrence of chronic and infectious diseases accelerate the market growth.

Market Segmentation By Product and Service, By Application, By Manufacturer Type, and By End User
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global in vitro diagnostics (IVD) quality control market covers segments such as product and service, application, manufacturer type, and end user. On the basis of product and service, the sub-markets include data management solutions, quality control products, and quality assurance services. On the basis of application, the sub-markets include immunochemistry, microbiology, coagulation/hemostasis, clinical chemistry, molecular diagnostics, hematology, and other applications. On the basis of manufacturer type, the sub-markets include OEMs, and third-party control manufacturers. On the basis of end user, the sub-markets include clinical laboratories, hospitals, research and academic institutes, and other end users.

Companies Profiled:

The report provides profiles of the companies in the market such as Bio-Rad Laboratories, Inc., LGC Group (acquires Seracare Life Sciences), Randox Laboratories Ltd., Siemens Healthcare Private Limited, Technopath Clinical Diagnostics, Sun Diagnostics, LLC, Ortho Clinical Diagnostics, Sysmex Corporation, BIOMÉRIEUX, and BD.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the in vitro diagnostics (IVD) quality control market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global in vitro diagnostics (IVD) quality control market was valued at USD 25962.7 Million in 2022.
It is likely to grow at a CAGR of 10.4% during the forecast period 2023-2030.
The global in vitro diagnostics (IVD) quality control market is estimated to reach USD 64094.9 Million by the end of 2030.
North America is anticipated to exhibit high demand for in vitro diagnostics (IVD) quality control market during the forecast period.
Bio-Rad Laboratories, Inc., LGC Group (acquires Seracare Life Sciences), Randox Laboratories Ltd., Siemens Healthcare Private Limited, Technopath Clinical Diagnostics, Sun Diagnostics, LLC, Ortho Clinical Diagnostics, Sysmex Corporation, BIOMÉRIEUX, and BD.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.